Skip to main content

FDA recall, , Moderate risk

Philips Azurion Systems

Philips Azurion systems may have table movements impacted due to mechanical wear of the Float Tabletop control.

What happened

Philips Medical Systems Nederland B.V. of Best, Netherlands, recalled 5,537 Philips Azurion systems not configured with an optional auxiliary pan handle, including models such as Azurion 3 M12, Azurion 3 M15, Azurion 5 M12, Azurion 5 M20, Azurion 7 B12, and Azurion 7 B20. The recall was prompted by a potential safety issue where longitudinal and transverse table movements may be impacted due to mechanical wear of the Float Tabletop control on the control module.

The recall began on April 28, 2026, and was added to the FDA's Enforcement Report on May 21, 2026.

Distribution was nationwide and international, including Albania, Algeria, Argentina, Armenia, Australia, Austria, Azerbaijan, Bangladesh, Belarus, Belgium, Bolivia, Bosnia and Herzegovina, Brazil, Canada, Chile, Côte d'Ivoire, El Salvador, Estonia, Greece, Honduras, Hong Kong, Iceland, Indonesia, Iraq, Japan, Kyrgyzstan, Malaysia, Malta, Moldova, Nepal, New Zealand, Philippines, Qatar, Singapore, South Africa, Sri Lanka, Syrian Arab Republic, Tanzania, Turkmenistan, Vietnam, Yemen.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Affected if its model number and UDI-DI are listed under that product.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Azurion 3 M12

    Model number
    • 722063
    • 722229
    UDI-DI
    • 00884838085275
    • 00884838116726
    • 00884838085282
    • 00884838099210
    • 00884838116733
    • 00884838103276
    • 00884838099227
    • 00884838116740
    • 00884838099234
    • 0884838099234
    • 00884838116757
    • 00884838110564
    • 00884838085350
    • 00884838099265
    • 00884838116788
    • 00884838085367
    • 00884838099272
    • 00884838116801
    • 00884838085251
    • 0088483808525
    • 00884838099241
    • 00884838116764
    • 00884838085268
    • 00884838099258
    • 84838099258
    • 6600558517
    • 00884838116771
    • 00884838110571
  2. Azurion 3 M15

    Model number
    • 722222
    • 722064
    • 722280
    • 722230
  3. Azurion 5 M12

    Model number
    • 722227
    • 722231
  4. Azurion 5 M20

    Model number
    • 722228
    • 722232
    • 722281
  5. Azurion 7 B12

    Model number
    • 722067
    • 722225
    • 722235
  6. Azurion 7 B20

    Model number
    • 722068
    • 722226
    • 722236
  7. Azurion 7 M12

    Model number
    • 722078
    • 722223
    • 722233
  8. Azurion 7 M20

    Model number
    • 722079
    • 722224
    • 722234
    • 722282

Recall details

Company began the recall
Sold in

Nationwide distribution. International distribution to Albania, Algeria, Argentina, Armenia, Australia, Austria, Azerbaijan, Bangladesh, Belarus, Belgium, Bolivia, Bosnia and Herzegovina, Brazil, Canada, Chile, C¿te D'Ivoire, El Salvador, Estonia, Greece, Honduras, Hong Kong, Iceland, Indonesia, Iraq, Japan, Kyrgyzstan, Malaysia, Malta, Moldova, Nepal, New Zealand, Philippines, Qatar, Singapore, South Africa, Sri Lanka, Syrian Arab Republic, Tanzania, Turkmenistan, Vietnam, Yemen

Company
PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.Best, Netherlands
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98812
Recall number
Z-2225-2026
Quantity recalled
5,537 units

All recalls from PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 2, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)